Skip to main content

Market Overview

Mid-Afternoon Market Update: Dow Jumps Over 100 Points; Cooper Tire Shares Jump


Toward the end of trading Monday, the Dow traded up 0.40% to 31,621.04 while the NASDAQ fell 1.57% to 13,656.22. The S&P also fell, dropping 0.28% to 3,895.94.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 28,134,270 cases with around 498,900 deaths. India confirmed a total of at least 11,005,850 confirmed cases and 156,380 deaths, while Brazil reported over 10,168,170 COVID-19 cases with 246,500 deaths. In total, there were at least 111,415,030 cases of COVID-19 worldwide with over 2,467,200 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares rose 4.4% on Monday. Meanwhile, top gainers in the sector included GasLog Ltd. (NYSE: GLOG), up 20%, and SM Energy Company (NYSE: SM), up 22%.

In trading on Monday, utilities shares fell by 2.4%.

Top Headline

DISH Network Corporation (NASDAQ: DISH) reported better-than-expected earnings for its fourth quarter.

DISH reported quarterly earnings of $1.24 per share, beating analysts’ estimates of $0.75 per share. The company’s quarterly sales came in at $4.56 billion, versus expectations of $4.42 billion.

Equities Trading UP

Rodgers Silicon Valley Acquisition Corp. (NASDAQ: RSVA) shares shot up 40% to $22.08. Enovix will go public through a merger with Rodgers Silicon Valley Acquisition Corp.

Shares of Celsion Corporation (NASDAQ: CLSN) got a boost, shooting 68% to $3.1989 after the company received FDA Fast Track designation for GEN-1 in advanced ovarian cancer.

Cooper Tire & Rubber Company (NYSE: CTB) shares were also up, gaining 30% to $56.97 after the company announced it will be acquired by Goodyear around $2.8 billion. Cooper Tire & Rubber also reported Q4 results.

Check out these big movers of the day

Equities Trading DOWN

Otonomy, Inc. (NASDAQ: OTIC) shares tumbled 42% to $3.11 after the company announced that its Phase 3 clinical trials of OTIVIDEX in patients with Meniere's disease did not meet its primary endpoint.

Shares of Ebix, Inc. (NASDAQ: EBIX) were down 40% to $30.30 after the company reaffirmed business forecast for FY 2021.

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was down, falling 33% to $4.64 after the company announced the FDA concluded from their initial review that the current level of NurOwn clinical data does not provide the threshold of substantial evidence that FDA is seeking to support a biologics license application.


In commodity news, oil traded up 4.1% to $61.69, while gold traded up 1.7% to $1,807.80.

Silver traded up 3.3% Monday to $28.165 while copper rose 1.8% to $4.1465.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.44%, the Spanish Ibex Index fell 0.48% and the German DAX 30 declined 0.31%. Meanwhile, the French CAC 40 fell 0.11%, London’s FTSE 100 fell 0.18% and Italy’s FTSE MIB fell 0.55%.

German Ifo Business Climate indicator increased to 92.4 in February from a revised reading of 90.3 in the earlier month.



The Chicago Fed National Activity Index rose to 0.66 in January versus a revised reading of 0.41 in December.

The index of leading economic indicators rose 0.5% for January.

The Dallas Fed manufacturing index rose 10.2 points to a reading of 17.2 in February .

Check out the full economic calendar here


Related Articles (CLSN + BCLI)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Small Cap Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at